⌘K
Loading ticker…
As of 2026-08-24, MiNK Therapeutics, Inc. Common Stock (INKT) has a 3-month relative strength percentile of 65 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.3%, relative volume 0.92×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
INKT is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $519K notional.
Held by 2 ETFs · $625K across latest filings · largest weight 0.00% (VXF).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $519K | — |
| VXFVanguard Extended Market ETF | 0.00% | $106K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | INKT Jan avg: 1.38% median: -3.37% win: 50% σ: 22.61% n: 4 2022-04-12 → 2026-07-31 | INKT Feb avg: -3.51% median: -4.67% win: 25% σ: 7.61% n: 4 2022-04-12 → 2026-07-31 | INKT Mar avg: -3.84% median: -3.65% win: 0% σ: 2.16% n: 4 2022-04-12 → 2026-07-31 | INKT Apr avg: -0.75% median: -5.54% win: 40% σ: 12.61% n: 5 2022-04-12 → 2026-07-31 | INKT May avg: -8.03% median: -2.02% win: 0% σ: 12.90% n: 5 2022-04-12 → 2026-07-31 | INKT Jun avg: 1.81% median: -2.14% win: 40% σ: 11.03% n: 5 2022-04-12 → 2026-07-31 | INKT Jul avg: 15.20% median: -7.09% win: 20% σ: 50.47% n: 5 2022-04-12 → 2026-07-31 | INKT Aug avg: 14.60% median: -9.95% win: 25% σ: 57.83% n: 4 2022-04-12 → 2026-07-31 (current) | INKT Sep avg: -13.25% median: -13.59% win: 0% σ: 10.47% n: 4 2022-04-12 → 2026-07-31 | INKT Oct avg: -2.12% median: -2.26% win: 50% σ: 4.80% n: 4 2022-04-12 → 2026-07-31 | INKT Nov avg: 0.49% median: 2.77% win: 75% σ: 19.25% n: 4 2022-04-12 → 2026-07-31 | INKT Dec avg: 0.40% median: 0.20% win: 50% σ: 4.69% n: 4 2022-04-12 → 2026-07-31 |